Old Web
English
Sign In
Acemap
>
authorDetail
>
Shu-Ping Hsueh
Shu-Ping Hsueh
Medicine
Pharmacology
Gemcitabine
Gemcitabine Hydrochloride
Pharmacokinetics
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open-label, exploratory, limited dose escalation study to evaluate the pharmacokinetics, safety and tolerability of gemcitabine hydrochloride oral formulation in subjects with malignant tumors.
2015
Journal of Clinical Oncology
Nashat Y. Gabrail
Sharad A. Ghamande
Michael H. Silverman
Carrie L. Smith
Hsiang-Ling Ho
C. Y. Huang
Shu-Ping Hsueh
C. C. Lin
Show All
Source
Cite
Save
Citations (0)
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors.
2014
Journal of Clinical Oncology
Chia-Chi Lin
Wu Chou Su
Jih-Hsiang Lee
Chih-Hung Hsu
Ann-Lii Cheng
C. C. Lin
Hsiang-Ling Ho
C. Y. Huang
Shu-Ping Hsueh
James Chih-Hsin Yang
Show All
Source
Cite
Save
Citations (0)
In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation
2013
Cancer Chemotherapy and Pharmacology
Wei Hua Hao
Jong-Jing Wang
Shu-Ping Hsueh
Pei-Jing Hsu
Li-Chien Chang
Chang-Shan Hsu
Kuang Yang Hsu
Show All
Source
Cite
Save
Citations (11)
1